UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of tumour–stromal interactions in modifying drug response: challenges and opportunities

Nature reviews. Drug discovery, 2013-03, Vol.12 (3), p.217-228

2013

Volltextzugriff (PDF)

Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235

Cancer research (Chicago, Ill.), 2009-07, Vol.69 (14), p.5835-5842

2009

Volltextzugriff (PDF)

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

Blood, 2007-12, Vol.110 (13), p.4417-4426

2007

Volltextzugriff (PDF)

Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma

Haematologica (Roma), 2011-08, Vol.96 (8), p.1170-1179

2011

Volltextzugriff (PDF)

Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib

Clinical cancer research, 2009-12, Vol.15 (23), p.7153-7160

2009

Volltextzugriff (PDF)

Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation

PloS one, 2011-07, Vol.6 (7), p.e20226

2011

Volltextzugriff (PDF)

The Role of the Bone Marrow Microenvironment in the Pathophysiology of Myeloma and Its Significance in the Development of More Effective Therapies

Hematology/oncology clinics of North America, 2007-12, Vol.21 (6), p.1007-1034

2007

Volltextzugriff (PDF)

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells

Molecular cancer therapeutics, 2008-05, Vol.7 (5), p.1121-1129

2008

Volltextzugriff (PDF)

Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells

Molecular cancer therapeutics, 2007-07, Vol.6 (7), p.1951-1961

2007

Volltextzugriff (PDF)

Introduction to the “Has the Fed Failed?” Special Section

Journal of macroeconomics, 2012-09, Vol.34 (3), p.567-568

Douglas McMillin, W.

2012

Volltextzugriff (PDF)

Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ

Journal of breast cancer, 2012-09, Vol.15 (3), p.273

2012

Volltextzugriff (PDF)

High-throughput approaches to discover novel immunomodulatory agents for cancer

Oncoimmunology, 2012-11, Vol.1 (8), p.1406-1408

2012

Volltextzugriff (PDF)

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

Nature medicine, 2010-04, Vol.16 (4), p.483-489

2010

Volltextzugriff (PDF)

Author Correction: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

Nature medicine, 2024-04, Vol.30 (4), p.1214-1214

2024

Volltextzugriff (PDF)

In vitro anti‐myeloma activity of the Aurora kinase inhibitor VE‐465

British journal of haematology, 2009-12, Vol.147 (5), p.672-676

2009

Volltextzugriff (PDF)

Nominal GDP versus price level targeting: An empirical evaluation

Journal of economics and business, 2020-05, Vol.109, p.105890, Article 105890

2020

Volltextzugriff (PDF)

Inhibition of Tumor Cells Interacting with Stromal Cells by Xanthones Isolated from a Costa Rican Penicillium sp

Journal of natural products (Washington, D.C.), 2012-04, Vol.75 (4), p.793-797

2012

Volltextzugriff (PDF)

Discovery of a Potent, Covalent BTK Inhibitor for B‑Cell Lymphoma

ACS chemical biology, 2014-05, Vol.9 (5), p.1086-1091

2014

Volltextzugriff (PDF)

Accessory Cells of the Microenvironment Protect Multiple Myeloma from T-Cell Cytotoxicity through Cell Adhesion-Mediated Immune Resistance

Clinical cancer research, 2013-10, Vol.19 (20), p.5591-5601

2013

Volltextzugriff (PDF)

Molecular and cellular effects of NEDD8-activating enzyme inhibition in myeloma

Molecular cancer therapeutics, 2012-04, Vol.11 (4), p.942-951

2012

Volltextzugriff (PDF)

Bernanke versus Taylor: a post mortem

Applied economics, 2015-09, Vol.47 (43), p.4574-4589

2015

Volltextzugriff (PDF)

Cross-Country Variation in the Liquidity Effect: The Role of Financial Markets

The Economic journal (London), 2004-10, Vol.114 (498), p.890-915

2004

Volltextzugriff (PDF)

Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune function

Blood, 2012-04, Vol.119 (15), p.e131-e138

2012

Volltextzugriff (PDF)

Introduction to the “Has Macro Progressed?” Special Section

Journal of macroeconomics, 2012-03, Vol.34 (1), p.1-1

Douglas McMillin, W.

2012

Volltextzugriff (PDF)

Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies

Blood, 2010-07, Vol.116 (4), p.593-602

2010

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(155)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of tumour–stromal interactions in modifying drug response: challenges and opportunities

Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235

The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia

Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma

Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib

Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation

The Role of the Bone Marrow Microenvironment in the Pathophysiology of Myeloma and Its Significance in the Development of More Effective Therapies

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells

Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells

Introduction to the “Has the Fed Failed?” Special Section

Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ

High-throughput approaches to discover novel immunomodulatory agents for cancer

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

Author Correction: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

In vitro anti‐myeloma activity of the Aurora kinase inhibitor VE‐465

Nominal GDP versus price level targeting: An empirical evaluation

Inhibition of Tumor Cells Interacting with Stromal Cells by Xanthones Isolated from a Costa Rican Penicillium sp

Discovery of a Potent, Covalent BTK Inhibitor for B‑Cell Lymphoma

Accessory Cells of the Microenvironment Protect Multiple Myeloma from T-Cell Cytotoxicity through Cell Adhesion-Mediated Immune Resistance

Molecular and cellular effects of NEDD8-activating enzyme inhibition in myeloma

Bernanke versus Taylor: a post mortem

Cross-Country Variation in the Liquidity Effect: The Role of Financial Markets

Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune function

Introduction to the “Has Macro Progressed?” Special Section

Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies

Suchergebnisse filtern